EndoChoice today announced the closing of its initial public offering of 7,302,500 shares of its common stock at a price to the public of $15.00 per share, which included an additional 702,500 shares sold by the company and 250,000 shares sold by certain selling stockholders pursuant to the exercise in full of the underwriters' option to purchase additional shares. Total proceeds to EndoChoice from the offering, including proceeds from the option exercise, after deducting underwriting discounts and commissions and estimated offering expenses, were approximately $94.9 million.
J.P. Morgan and BofA Merrill Lynch acted as joint book-running managers for the offering. William Blair and Stifel acted as co-managers for the offering.
Source: Metro Atlanta CEO. http://metroatlantaceo.com/news/2015/06/endochoice-ipo-raises-949-million/